v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
May 31, 2025
Aug. 31, 2024
Current    
Cash $ 4,591,761 $ 6,499,885
Marketable securities 33,540 55,807
Accounts receivable 358,129 154,477
Prepaid expenses and other current assets 823,348 1,187,817
Total Current Assets 5,806,778 7,897,986
Non-current assets, net    
Long-term receivables 64,014 63,575
Right of use assets 114,015 134,843
Intellectual property, net 516,420 516,676
Property & equipment, net 240,139 254,709
Total Non-current Assets 934,588 969,803
TOTAL ASSETS 6,741,366 8,867,789
Current Liabilities    
Accounts payable and accrued liabilities 1,458,259 1,066,409
Deferred revenue 0 4,963
Lease liability, current 29,872 28,047
Total Current Liabilities 1,488,131 1,099,419
Lease liabilities - non-current 86,714 109,319
TOTAL LIABILITIES 1,574,845 1,208,738
Stockholders' Equity    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 19,559,179 and 19,459,179, respectively, at May 31, 2025, and 15,810,205 at August 31, 2024 19,559 15,810
Additional paid-in capital 66,378,362 59,599,178
Accumulated Deficit (60,764,775) (51,558,772)
Accumulated other comprehensive loss (81,073) (19,816)
Equity attributable to shareholders of Lexaria 5,552,073 8,036,400
Non-controlling Interest (385,552) (377,349)
Total Stockholders' Equity 5,166,521 7,659,051
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 6,741,366 $ 8,867,789